Vijaya Diagnostic (VIJAYA) | Stock Overview & Key Data
Vijaya Diagnostic Performance Comparison
Stock Range
Today's Range
Low: ₹990.55
High: ₹1,022.00
on October 1, 2025
52 Week Range
Low: ₹740.00
High: ₹1,275.00
on February 17, 2025
on January 13, 2025
All-Time High: ₹1,275.00 on January 13, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR104.8B
EPS
14.58
P/E Ratio (TTM)
68.59
Forward P/E
50.20
P/B Ratio
12.88
PEG Ratio
3.00
Div. Yield
0.30%
ROE
17.90%
Beta
-0.111
Debt to Equity
39.99
Financial Highlights
Profitability
Gross Margin
88.61%
Operating Margin
27.99%
Profit Margin
21.04%
Returns and Earnings
Return on Assets (TTM)
11.23%
Return on Equity (TTM)
17.90%
EBITDA
INR2.9B
Net Income (TTM)
INR1.5B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR69.49
Quarterly Revenue Growth (YoY)
20.40%
Quarterly Earnings Growth (YoY)
22.30%
Dividend Information
Last 12-Month Dividend
₹3.00
Current Dividend Yield
0.30%
3-Year Average Dividend Yield
0.19%
3-Year Average Annual Dividend
₹1.67
3-Year Total Dividends
₹5.00
Ex-Dividend Date
August 29, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Vijaya Diagnostic VIJAYA | 104.75B Mid-cap | -4.61% | -3.82% | 2.36% | 3.12% | -5.56% | 1.47% | 117.04% | 60.08% |
| Dr. Lal PathLabs LALPATHLAB | 265.33B Large-cap | -4.11% | -3.16% | 14.23% | 32.06% | 3.79% | -9.34% | 29.77% | 54.23% |
| Syngene SYNGENE | 250.35B Large-cap | -3.23% | -1.94% | -2.51% | -13.27% | -29.16% | -28.05% | 10.41% | 11.27% |
| Sai Life Sciences SAILIFE | 180.28B Mid-cap | -0.54% | 4.98% | 13.77% | 17.23% | 17.04% | 26.08% | 26.08% | 26.08% |
| Metropolis METROPOLIS | 106.47B Mid-cap | -1.97% | -5.00% | 19.34% | 33.83% | -0.75% | -8.67% | 32.94% | 3.77% |
| Thyrocare THYROCARE | 64.96B Mid-cap | -4.77% | -10.95% | 17.89% | 59.18% | 24.62% | 42.83% | 65.94% | 7.48% |
Ownership & Short Interest
Insider Ownership
52.61%
Institutional Ownership
39.22%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
106K
Average 90-Day Volume
155K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is VIJAYA's 52-week high and low?
- In the last 52 weeks, Vijaya Diagnostic reached a high of ₹1,275.00 (on January 13, 2025) and a low of ₹740.00 (on February 17, 2025).
- What is the market cap and P/E ratio for VIJAYA?
- Curious about Vijaya Diagnostic's size and valuation? Its market capitalization stands at 104.75B. When it comes to valuation, the P/E ratio (trailing twelve months) is 68.59, and the forward P/E (looking ahead) is 50.20.
- Does VIJAYA pay dividends? If so, what's the yield?
- Yes, Vijaya Diagnostic is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.30%, and the company has paid an average of ₹1.67 per share annually over the past 3 years.
- Who are Vijaya Diagnostic's main competitors or similar companies to consider before investing?
When looking at Vijaya Diagnostic, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Dr. Lal PathLabs
LALPATHLAB265.33B Healthcare Diagnostics & Research -9.34% 29.77% Syngene
SYNGENE250.35B Healthcare Diagnostics & Research -28.05% 10.41% Sai Life Sciences
SAILIFE180.28B Healthcare Diagnostics & Research 26.08% 26.08% Metropolis
METROPOLIS106.47B Healthcare Diagnostics & Research -8.67% 32.94% Thyrocare
THYROCARE64.96B Healthcare Diagnostics & Research 42.83% 65.94% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Vijaya Diagnostic Centre Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Vijaya Diagnostic's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 17.90%, the Debt to Equity ratio from the most recent quarter is 39.99, and its Gross Profit Margin stands at 88.61%.
- What is the recent revenue and earnings growth for VIJAYA?
- Looking at Vijaya Diagnostic's growth, its revenue over the trailing twelve months (TTM) was INR7B. Compared to the same quarter last year (YoY), quarterly revenue grew by 20.40%, and quarterly earnings saw a YoY growth of 22.30%.
- How much of VIJAYA stock is held by insiders and institutions?
- Wondering who owns Vijaya Diagnostic stock? Company insiders (like executives and directors) hold about 52.61% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 39.22%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.